X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3703) 3703
Newspaper Article (497) 497
Patent (426) 426
Publication (312) 312
Book Review (78) 78
Book / eBook (65) 65
Book Chapter (53) 53
Magazine Article (51) 51
Trade Publication Article (35) 35
Dissertation (31) 31
Conference Proceeding (28) 28
Reference (8) 8
Report (6) 6
Video Recording (2) 2
Web Resource (2) 2
Government Document (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1302) 1302
male (760) 760
female (753) 753
adult (478) 478
index medicus (444) 444
animals (378) 378
middle aged (344) 344
chemistry (300) 300
adolescent (288) 288
metallurgy (284) 284
child (268) 268
human necessities (263) 263
aged (240) 240
organic chemistry (193) 193
animal and vegetable oils, fats, fatty substances and waxes (177) 177
candles (177) 177
detergents (177) 177
fatty acids therefrom (177) 177
child, preschool (176) 176
oncology (176) 176
essential oils (164) 164
perfumes (164) 164
producing, refining and preservingfats, fatty substances (164) 164
hygiene (158) 158
medical or veterinary science (158) 158
infant (153) 153
preparations for medical, dental, or toilet purposes (143) 143
acyclic or carbocyclic compounds (140) 140
article (140) 140
research (132) 132
analysis (126) 126
medicine, general & internal (115) 115
mice (113) 113
rats (112) 112
prognosis (111) 111
microbiology (104) 104
detergent compositions (103) 103
foods or foodstuffs (103) 103
recovery of glycerol (103) 103
resin soaps (103) 103
soap or soap-making (103) 103
their treatment, not covered by other classes (103) 103
use of single substances as detergents (103) 103
tobacco (101) 101
cigarettes (100) 100
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (100) 100
preservation of foods or foodstuffs, in general (100) 100
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (100) 100
cigars (99) 99
manufacture or preparation of tobacco for smoking orchewing (99) 99
smokers' requisites (99) 99
snuff (99) 99
risk factors (95) 95
biochemistry (92) 92
children (90) 90
treatment outcome (90) 90
time factors (84) 84
hematology (82) 82
abridged index medicus (75) 75
beer (75) 75
enzymology (75) 75
heterocyclic compounds (75) 75
mutation or genetic engineering (75) 75
spirits (75) 75
surgery (75) 75
vinegar (75) 75
wine (75) 75
pediatrics (74) 74
antineoplastic combined chemotherapy protocols - therapeutic use (71) 71
united states (69) 69
culture media (67) 67
research article (67) 67
dose-response relationship, drug (66) 66
pharmacology & pharmacy (66) 66
biochemistry & molecular biology (64) 64
ecology (63) 63
health aspects (63) 63
physics (63) 63
diagnosis (62) 62
general tagging of cross-sectional technologies spanning over several sections of the ipc (62) 62
general tagging of new technological developments (62) 62
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (62) 62
risk (61) 61
young adult (61) 61
compositions thereof (60) 60
follow-up studies (60) 60
microorganisms or enzymes (60) 60
propagating, preserving or maintaining microorganisms (60) 60
sebum - metabolism (60) 60
care and treatment (59) 59
dermatology (58) 58
cancer (57) 57
aged, 80 and over (56) 56
therapy (56) 56
expression (55) 55
age factors (54) 54
neurosciences (54) 54
double-blind method (53) 53
management (53) 53
mechanical engineering (53) 53
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (15) 15
Robarts - Stacks (11) 11
Gerstein Science - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
St. Michael's College (John M. Kelly) - 3rd Floor (5) 5
Online Resources - Online (4) 4
Victoria University E.J. Pratt - Stacks (4) 4
Knox College (Caven) - Stacks (3) 3
OISE - Stacks (3) 3
Regis College - Stacks (3) 3
St. Augustine's Seminary - Stacks (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Engineering & Comp. Sci. - Stacks (2) 2
Media Commons - Audio Visual (2) 2
Trinity College (John W Graham) - Wycliffe Storage (2) 2
UofT at Mississauga - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Knox College (Caven) - Storage (1) 1
Lakeridge Health Sciences - Online (1) 1
Pontifical Inst. Mediaeval Studies - Rare Book (1) 1
Trinity College (John W Graham) - Reference (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT Schools - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University Emmanuel College - Birge Storage (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4832) 4832
French (125) 125
German (52) 52
Spanish (17) 17
Portuguese (12) 12
Chinese (6) 6
Japanese (5) 5
Norwegian (4) 4
Russian (2) 2
Danish (1) 1
Dutch (1) 1
Korean (1) 1
Manx (1) 1
Polish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PSYCHOSOMATICS, ISSN 0033-3182, 11/2015, Volume 56, Issue 6, pp. 626 - 627
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
by Bosch, Jackie and Gerstein, Hertzel C and Dagenais, Gilles R and Díaz, Rafael and Dyal, Leanne and Jung, Hyejung and Maggiono, Aldo P and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, Leanne and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 309 - 318
Participants with impaired fasting glucose who were at risk for cardiovascular events were assigned to receive daily n−3 fatty acids or placebo and to receive... 
MEDICINE, GENERAL & INTERNAL | EVENTS | PREVENTION | FISH | RISK | CORONARY-HEART-DISEASE | OMEGA-3-FATTY-ACID INTAKE | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Treatment Failure | Cardiovascular Diseases - mortality | Female | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Double-Blind Method | Proportional Hazards Models | Glucose Intolerance - complications | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Prevention | Complications and side effects | Care and treatment | Patient outcomes | Dietary supplements | Causes of | Diabetes | Cardiovascular diseases | Fatty acids | Health aspects | Myocardial infarction | Arrhythmia | Diabetes mellitus | Lipids | Esters | Cardiovascular disease | Insulin | Glucose tolerance | Diet | Death | Supplementation | Diabetes mellitus (non-insulin dependent) | Heart diseases | Cardiovascular Diseases | Insulin, Long-Acting | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article